Bioequivalence and Bioavailability Forum • Quod licet Iovi

Quod licet Iovi [Two-Stage / GS Designs]

posted by mittyri – Russia, 2024-04-05 22:33 (457 d 16:07 ago) – Posting: # 23942
Views: 7,654

Hi Helmut,

❝ the manuscript was not accepted on March 12, 2024. The authors failed to demonstrate that the Type I Error is controlled (see this article why).

Didn't they mention this as a magic bullet argument? ;-)

;-)

—
Kind regards,
Mittyri

Complete thread:

Parallel Group Adaptive Designs Alex 2023-12-22 10:08 [Two-Stage / GS Designs]
- Strong Type I Error control + CI: Not yet… Helmut 2023-12-22 12:01
  - Strong Type I Error control + CI: Not yet… Alex 2024-01-08 16:22
    - Strong Type I Error control + CI: Not yet… Helmut 2024-01-09 09:48
  - Strong Type I Error control + CI: Not yet… roman_max 2024-04-04 15:18
    - Parallel design: Only simulation-based methods so far Helmut 2024-04-04 20:16
      - Parallel design: Only simulation-based methods so far roman_max 2024-04-15 21:46
- Parallel Group Adaptive Designs Achievwin 2024-01-05 11:53
  - Simulations highly recommended Helmut 2024-01-05 12:40
    - Simulations highly recommended Achievwin 2024-01-08 16:55
      - Simulations mandatory Helmut 2024-01-09 09:31
        
        Simulations mandatory Achievwin 2024-01-09 21:11
        
        Reviews are confidential Helmut 2024-01-09 22:10
        
        Reviews are confidential Achievwin 2024-01-19 15:11
        
        Not accepted and for a reason… Helmut 2024-04-04 20:22
        
        Quod licet Iovimittyri 2024-04-05 20:33
        
        Non licet bovi Helmut 2024-04-05 21:50
        
        Non licet bovi mittyri 2024-04-05 22:21
        
        Quod licet bove? Helmut 2024-04-06 07:21

Admin contact
23,428 posts in 4,929 threads, 1,682 registered users;
65 visitors (0 registered, 65 guests [including 16 identified bots]).
Forum time: 14:40 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other. Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz